HB 2387 – OregonStatus: Inactive / Dead
Year Introduced: 2017
Requires pharmaceutical manufacturer to provide 60 days’ advance notice of increase in cost of prescription drug that exceeds 3.4 percent over 12-month period. Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services specified information about prescription drug costs and about patient assistance programs. Requires pharmaceutical manufacturer to pay to department cost of prescription drug that exceeds specified threshold. Prohibits Public Employees’ Benefit Board, Oregon Educators Benefit Board, health care service contractors, multiple employer welfare arrangements and carriers for small employer, group or individual health benefit plans from requiring enrollees to incur out-of-pocket costs for prescription drugs that exceed specified maximums. Authorizes civil penalties for failing to report or to make payments required by Oregon Premium Protection Program.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.